FIELD: medicine; ophthalmology.
SUBSTANCE: invention can be used for local corneal crosslinking in case of keratectasia. For this, deepithelialization of the cornea is carried out in the paraoptic zone 2-4 mm wide. A solution of riboflavin 0.1% is installed dripwise for 30 minutes with an interval of 2 minutes. In the paraoptic zone, irradiation is carried out with a power density of 6 mW/cm2 for 15 min in the form of semicircles located in accordance with the ectasia zone, and with simultaneous installations of riboflavin every three minutes.
EFFECT: invention provides a reduction in the time of intervention with a decrease in intraoperative infection and mechanical trauma of the surface layers of the cornea and a corresponding prevention of possible postoperative complications, a reduction in the rehabilitation period and an increase in the efficiency of the operation.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING DONOR MATERIAL FOR KERATOPLASTY | 2022 |
|
RU2806987C1 |
| METHOD FOR CORNEAL COLLAGEN CROSSLINKING IN KERATECTASIAS OF VARIOUS GENESIS | 2021 |
|
RU2778968C1 |
| METHOD FOR CONDUCTING ULTRAVIOLET CORNEAL CROSS-LINKING USING BIOLENS WITH THIN CORNEA | 2020 |
|
RU2739995C1 |
| METHOD FOR ULTRAVIOLET CORNEAL CROSS-LINKING TAKING INTO ACCOUNT TOPOGRAPHIC PACHYMETRY AND KERATOTOPOGRAPHY IN PATIENTS WITH A THIN CORNEA | 2020 |
|
RU2735377C1 |
| METHOD OF THE TREATMENT OF PERFORATED ULCER OF THE KERATOGRAFT | 2022 |
|
RU2803167C1 |
| OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
| METHOD FOR PERFORMING MEDICAL-OPTICAL KERATOPLASTY FOR KERATECTASIAS OF VARIOUS ORIGINS | 2020 |
|
RU2742521C1 |
| METHOD OF TREATING KERATOCONUS IN PATIENTS WITH THIN CORNEA | 2013 |
|
RU2522386C1 |
| OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
| METHOD OF TREATMENT OF KERATECTASIA BY THE METHOD OF PULSE ACCELERATED ULTRAVIOLET CROSSLINKING OF CORNEA | 2017 |
|
RU2682494C1 |
